'''Almokalant''' is a [[drug]] used to treat [[Antiarrhythmic agent|arrhythmia]].<ref>{{cite journal |vauthors=Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI | title =  Torsades de pointes with Almokalant, a new class III antiarrhythmic drug | journal = American Heart Journal | year = 1993 | volume = 126 | issue = 4 | pages = 1008–1011 | doi=10.1016/0002-8703(93)90726-p}}</ref>  It is a [[potassium channel blocker]]. It has been found to have [[teratogenic]] effects in rats.<ref>{{Cite journal|title = Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species|journal = Reproductive Toxicology (Elmsford, N.Y.)|date = 1999-04-01|issn = 0890-6238|pmid = 10213516|pages = 93–101|volume = 13|issue = 2|first = K.|last = Wellfelt|first2 = A. C.|last2 = Sköld|first3 = A.|last3 = Wallin|first4 = B. R.|last4 = Danielsson}}</ref>
